Showing results (11-20 of 956) with videos related to
Sort By:
Pageof 96
Optics Express|May 8, 2009
Angular dispersion compensation for acousto-optic devices used for ultrashort-pulsed laser micromachiningB K Ngoi, K Venkatakrishnan, L E Lim, et al.Clinical Pharmacology and Therapeutics|November 3, 2016
Enhancing value of clinical pharmacodynamics in oncology drug development: An alliance between quantitative pharmacology and translational scienceK Venkatakrishnan, J A EcsedyJournal of Biomedical Nanotechnology|September 25, 2013
The influence of laser-induced 3-D titania nanofibrous platforms on cell behaviorAmirhossein Tavangar, Bo Tan, K VenkatakrishnanActa Biomaterialia|March 1, 2011
Synthesis of bio-functionalized three-dimensional titania nanofibrous structures using femtosecond laser ablationAmirhossein Tavangar, Bo Tan, K VenkatakrishnanClinical Pharmacology and Therapeutics|June 3, 2015
Physiologically based and population PK modeling in optimizing drug development: A predict-learn-confirm analysisA Suri, S Chapel, C Lu, et al.Applied Optics|April 18, 2002
Phase-shifting interferometry immune to vibrationB K Ngoi, K Venkatakrishnan, N R SivakumarXenobiotica; the Fate of Foreign Compounds in Biological Systems|October 31, 2007
Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug-drug interaction risk assessmentK Venkatakrishnan, R S Obach, A Rostami-HodjeganPeptides|November 11, 1998
Identification of glycine-extended CCK peptides in endocrine cells and modulation of CCK amide and CCK Gly content and secretion from endocrine tumor cells by an inhibitor of amidationM C Beinfeld, M D Perloff, K VenkatakrishnanJournal of Clinical Pharmacology|June 4, 1999
Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): implications for interactions with enzyme-inducing drugsK Venkatakrishnan, L L von Moltke, D J GreenblattJournal of Pharmaceutical Sciences|April 3, 1999
Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high affinity component as an index of CYP1A2 activityK Venkatakrishnan, L L von Moltke, D J GreenblattPageof 96